http://www.sfubiz.ca/sma/wp-content/uploads/2013/04/DTC-Advertising-EN.sflb_. jpg. http://www.havidol.com/images/content_female.jpg. Direct-to-Consumer Pharmaceutical Marketing. Power Point by Joshua Friesen. http://pharmaregulations.files.wordpress.com/2010/10/wizardofid20522440207231.gif.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Power Point by Joshua Friesen
How can DTCPA be reformed so as to make it a beneficial practice for patients?
But why does it need to be reformed?
>55,000 DEATHS practice for patients?
$321 million fine
$4.85 billion payout to patients
“Relapanaxis generally very well tolerated. Side effects tend to be mild and often go away in a short time. If side effects do occur they may include: nausea, upset stomach and diarrhea. It is important for you to know that few people were bothered enough by these side effects to stop taking Relapanax.””
“The most common side effects were headache (3%) and stomach ache (2%). Side effects generally did not last for a long time. All side effects disappeared within two weeks. Very few people (1%) stopped taking Relapanax due to these side effects.’’
Davis, Joel. "The Effect of Qualifying Language on Perceptions of Drug Appeal, Drug Experience, and Estimates of Side-Effect Incidence in DTC Advertising." Journal of Health Communications. 12.1 (2007): 607- 622. Web.
Johar, Kanika. "An Insider's Perspective: Defense of the Pharmaceutical Industry's MarketingPractices." Albany Law Review. 76.1 (2013): 299- 334. Web.
Ventola, Lee. "Direct-to-Consumer Pharmaceutical Advertising Therapeutic or Toxic." P&T. 36.10 (2011): 669-84. Web.